The Latest in Thrombosis

Hematology Times

Secondary prophylaxis reduces bleeding in hemophilia

July 13, 2012

Thrombosis

Hematology Times

Hemophilia patients plagued by professional challenges

July 11, 2012

Thrombosis

Hematology Times

Drug for aHUS effective but expensive

June 26, 2012

Hematology Times

A new approach to heparin production

November 1, 2011

Thrombosis

Hematology Times

Eculizumab gets accelerated approval for aHUS

September 23, 2011

Hematology Times

Research indicates apixaban is superior to warfarin

August 29, 2011

Thrombosis

Hematology Times

Rivaroxaban noninferior to warfarin in AF patients

August 11, 2011

Thrombosis

Hematology Times

New antiplatelet agent approved by FDA

July 21, 2011

Thrombosis

Hematology Times

Rivaroxaban approved for thromboembolic events

July 12, 2011

Thrombosis

Hematology Times

FDA explains dabigatran dose approval

April 18, 2011

Thrombosis

Hematology Times

Dabigatran also recommended to treat AF

February 16, 2011

Thrombosis

Hematology Times

Dabigatran: lower hemorrhage risk than warfarin

November 19, 2010

Thrombosis

Hematology Times

FDA approves dabigatran for AF patients

October 20, 2010

Thrombosis

Hematology Times

FDA panel recommends dabigatran: 9-0

September 24, 2010

Thrombosis

Hematology Times

Dabigatran comparable to warfarin for acute VTE

December 15, 2009

Thrombosis